Searched for
PFIZER STOCK INCREASE
US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...- Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20%Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Will Trump tweet on Pfizer cut short the pharma rally?On July 1, Pfizer increased the prices of over 40 drugs including Viagra.
- Pfizer considers raising bid for AstraZeneca: ReportPfizer Inc is planning to return with a higher bid for British rival AstraZeneca Plc before the US drugmaker considers going hostile,
- Pfizer rallies 18% intraday, closes day 9% higher on parent's restructuring bidThe company said that a unit of its parent Pfizer Inc will buy about 61 per cent stake from two other units after an internal restructuring.
- Pfizer, Wyeth merger to add more value to stocksIndian units of global drug majors Pfizer and Wyeth have been star performers on Dalal Street, notching up gains of nearly 55% and 60%, res...
- Pfizer to buy back $10 b in stock in line with its repurchase strategyThis is the fourth major share repurchase programme for New York-based company in past two-and-a-half years.
- Pfizer, Astra deals to drive Aurobindo Pharma’s growthA ramp-up in its deal with Pfizer resulted in a decent growth in its US and Europe sales. The net profit also got a boost from a forex gain...
- Pfizer’s growth outlook seen strongThe Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past ...
- Pfizer hikes open offer price by 23%, but few takers seenPfizer has revised its open offer price for shares of its Indian subsidiary Pfizer India by almost 23% from Rs 675 to Rs 830 per share. As ...
- Pfizer's open offer for 34% in Indian arm to begin on June 15Pharma firm Pfizer India on Monday said the open offer by its parent firm for acquiring an additional 34 per cent stake in it has been resc...
- Pfizer's open offer for 34%c stake in Indian arm from June 10US-based pharmaceutical giant Pfizer said its $ 136 mn (Rs 680 crore) open offer to shareholders of its Indian arm will begin on June 10.
- Pharma cos shares extend gain on BSEShares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...
- Ranbaxy gets relief in Lipitor caseDomestic pharma firm Ranbaxy Laboratories has secured a favourable verdict from Canada's Federal Court in the 'Lipitor' case against global...
- Pfizer may cut jobs, rejig biz to tide over crisisPfizer will likely slash staff and accelerate merger and licencing deals as the pressure on it to improve its financial performance intensi...
- Pfizer Q2 up two fold at Rs 35.89 crGlobal pharmaceutical company, Pfizer Ltd on Wednesday posted an increase of over two fold in net profit after tax at Rs 35.89 crore for th...
Load More
